(Q38513243)

3 September 2017

1 reference

title

Hyperhomocysteinemia: Impact on Neurodegenerative Diseases (English)

1 reference

3 September 2017

1 reference

Meenakshi Sharma

1

1 reference

PubMed ID

26036286

3 September 2017

Manisha Tiwari

series ordinal

2

1 reference

PubMed ID

26036286

3 September 2017

Rakesh Kumar Tiwari

series ordinal

3

1 reference

3 September 2017

2 June 2015

1 reference

Basic and Clinical Pharmacology and Toxicology

3 September 2017

1 reference

3 September 2017

117

1 reference

3 September 2017

5

1 reference

3 September 2017

287-296

1 reference

Relevance of vitamins, homocysteine and other metabolites in neuropsychiatric disorders.

3 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Causes of vitamin B12 and folate deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Hyperhomocysteinemia due to methionine synthase deficiency, cblG: structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173L

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Effects of nitric oxide modulators on cardiovascular risk factors in mild hyperhomocysteinaemic rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Association between irisin and homocysteine in euglycemic and diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Resting brain perfusion and selected vascular risk factors in healthy elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Multiple extra macular branch retinal vein occlusions in hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Plasma homocysteine concentrations in the acute phase after central retinal vein occlusion in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Alzheimer's disease-do tauists and baptists finally shake hands?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Hyperhomocysteinemia is a risk factor for Alzheimer's disease in an Algerian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Association of homocysteine with hippocampal volume independent of cerebral amyloid and vascular burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Mild cognitive impairment, risk factors and magnetic resonance volumetry: role of probable Alzheimer's disease in the family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Physical exercise reverses glutamate uptake and oxidative stress effects of chronic homocysteine administration in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Effects of hydrated forms of C60 fullerene on amyloid 1-peptide fibrillization in vitro and performance of the cognitive task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Continuous exercise training and curcumin attenuate changes in brain-derived neurotrophic factor and oxidative stress induced by lead acetate in the hippocampus of male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Homocysteine in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Acute homocysteine rise after repeated levodopa application in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Methylenetetrahydrofolate reductase C677T genotype and PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Autism: many genes, common pathways?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Gender-specific effect of Mthfr genotype and neonatal vigabatrin interaction on synaptic proteins in mouse cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Autism, imprinting and epigenetic disorders: a metabolic syndrome linked to anomalies in homocysteine recycling starting in early life??

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

Huntingtin interacts with cystathionine beta-synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12424

21 January 2018

Identifiers

DOI

10.1111/BCPT.12424

1 reference

3 September 2017

1 reference

PubMed ID

26036286